Comparison of SIMOA and VEUS technologies for serum neurofilament light chain measurement in multiple sclerosis

被引:0
作者
Pelisek, Ondrej [1 ,2 ]
Kusnierova, Pavlina [3 ,4 ]
Hradilek, Pavel [1 ,2 ,3 ]
Horakova, Jana [1 ]
Svub, Krystof [1 ]
Siprova, Katerina [1 ]
Sobek, Ondrej [5 ]
Ganesh, Aravind [6 ,7 ,8 ]
Hanzlikova, Pavla [9 ]
Volny, Ondrej [1 ,2 ]
Revendova, Kamila Zondra [1 ,2 ]
机构
[1] Univ Hosp Ostrava, Dept Neurol, 17 Listopadu 1790-5, Ostrava 70800, Czech Republic
[2] Univ Hosp Ostrava, Blood Ctr, Ostrava, Czech Republic
[3] Univ Ostrava, Inst Lab Med, Fac Med, Ostrava, Czech Republic
[4] Univ Hosp Ostrava, Inst Lab Med, Ostrava, Czech Republic
[5] Topelex Ltd, Lab CSF Neuroimmunol Pathol & Special Diagnost, Prague, Czech Republic
[6] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Clin Neurosci & Community Hlth Sci, Calgary, AB, Canada
[7] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada
[8] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada
[9] Univ Hosp Ostrava, Dept Radiol, Ostrava, Czech Republic
关键词
Neurofilament light chain; Multiple sclerosis; Assays; Simoa; Veus;
D O I
10.1016/j.msard.2024.105815
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The gold standard for serum neurofilament light chain (sNfL) determination is the single molecule array (SIMOA), the use of which is limited by availability and cost. The VEUS method is a fully automated, userfriendly diagnostic system requiring no sample preparation, with high reported sensitivity, multiplexing capability, and rapid diagnostics. The aim of this study was to compare the SIMOA and VEUS methods for determining sNfL levels in patients with multiple sclerosis (MS). Methodology: A single-centre cross-sectional study was conducted at the MS Centre of University Hospital Ostrava. Patients were enrolled in the study from January 18 to January 31, 2024. Inclusion criteria were: 1) diagnosis of MS according to the revised 2017 McDonald criteria, 2) age >= 18 years, and 3) signed informed consent. The NF-light V2 diagnostic kit (SIMOA, Quanterix) and the Singleplex Neurology assay kit (VEUDx, EZDiatech) were used to determine sNfL concentrations. The two methods were compared by use of Spearman correlation, Passing-Bablok regression, and Bland-Altman analysis. Results: A total of 49 patients were included in the study, of whom 39 (79.6 %) were female. The median sNfL concentration was 7.73 (IQR 5.80-9.93) ng/L determined by SIMOA and 1.31 (IQR 1.18-1.65) ng/L by VEUS. We did not find a correlation between SIMOA and VEUS (rs = 0.025, p = 0.866). Passing-Bablok regression demonstrated a systematic and proportional difference between the two methods. A significant disagreement between them was also confirmed by the Bland-Altman plots. On average, sNfL values measured by SIMOA were 3.56 ng/L (95 % CI 0.78 to 6.34) higher than those measured by VEUS. Conclusion: Our investigation uncovered noteworthy disparities between the SIMOA and VEUS techniques in determining sNfL levels. Specifically, the VEUS technique systematically produces lower estimates of sNFL levels. This substantial variance emphasizes the importance of carefully evaluating assay methods when quantifying sNfL.
引用
收藏
页数:5
相关论文
共 18 条
[1]   Magnetic resonance diffusion-tensor imaging metrics in High Grade Gliomas: Correlation with IDH1 gene status in WHO 2016 era [J].
Augelli, Raffaele ;
Ciceri, Elisa ;
Ghimenton, Claudio ;
Zoccatelli, Giada ;
Bucci, Alessandra ;
Nicolato, Antonio ;
Beltramello, Alberto ;
Pinna, Giampietro ;
Ricciardi, Giuseppe K. .
EUROPEAN JOURNAL OF RADIOLOGY, 2019, 116 :174-179
[2]   Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions [J].
Ayrignac, Xavier ;
Rigau, Valerie ;
Lhermitte, Benoit ;
Vincent, Thierry ;
de Champfleur, Nicolas Menjot ;
Carra-Dalliere, Clarisse ;
Charif, Mahmoud ;
Collongues, Nicolas ;
de Seze, Jerome ;
Hebbadj, Sonia ;
Ahle, Guido ;
Oesterle, Helene ;
Cotton, Francois ;
Durand-Dubief, Francoise ;
Marignier, Romain ;
Vukusic, Sandra ;
Taithe, Frederic ;
Cohen, Mikael ;
Guennoc, Anne-Marie ;
Kerbrat, Anne ;
Edan, Gilles ;
Carsin-Nicol, Beatrice ;
Allou, Thibaut ;
Sablot, Denis ;
Thouvenot, Eric ;
Ruet, Aurelie ;
Magy, Laurent ;
Boncoeur-Martel, Marie-Paule ;
Labauge, Pierre ;
Kremer, Stephane .
JOURNAL OF NEUROLOGY, 2019, 266 (07) :1743-1755
[3]   Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study [J].
Benkert, Pascal ;
Meier, Stephanie ;
Schaedelin, Sabine ;
Manouchehrinia, Ali ;
Yaldizli, Ozgur ;
Maceski, Aleksandra ;
Oechtering, Johanna ;
Achtnichts, Lutz ;
Conen, David ;
Derfuss, Tobias ;
Lalive, Patrice H. ;
Mueller, Christian ;
Muller, Stefanie ;
Naegelin, Yvonne ;
Oksenberg, Jorge R. ;
Pot, Caroline ;
Salmen, Anke ;
Willemse, Eline ;
Kockum, Ingrid ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Gobbi, Claudio ;
Kappos, Ludwig ;
Wiendl, Heinz ;
Berger, Klaus ;
Sormani, Maria Pia ;
Granziera, Cristina ;
Piehl, Fredrik ;
Leppert, David ;
Kuhle, Jens .
LANCET NEUROLOGY, 2022, 21 (03) :246-257
[4]   The potential of serum neurofilament as biomarker for multiple sclerosis [J].
Bittner, Stefan ;
Oh, Jiwon ;
Havrdova, Eva Kubala ;
Tintore, Mar ;
Zipp, Frauke .
BRAIN, 2021, 144 :2954-2963
[5]   Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis [J].
Disanto, Giulio ;
Barro, Christian ;
Benkert, Pascal ;
Naegelin, Yvonne ;
Schadelin, Sabine ;
Giardiello, Antonella ;
Zecca, Chiara ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Leppert, David ;
Kappos, Ludwig ;
Gobbi, Claudio ;
Kuhle, Jens .
ANNALS OF NEUROLOGY, 2017, 81 (06) :857-870
[6]   Analytical and pre-analytical aspects of neurofilament light chain determination in biological fluids [J].
Fialova, L. ;
Noskova, L. ;
Kalousova, M. ;
Zima, T. ;
Uher, T. ;
Bartos, A. .
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (01) :11-16
[7]   MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines [J].
Filippi, Massimo ;
Rocca, Maria A. ;
Ciccarelli, Olga ;
De Stefano, Nicola ;
Evangelou, Nikos ;
Kappos, Ludwig ;
Rovira, Alex ;
Sastre-Garriga, Jaume ;
Tintore, Mar ;
Frederiksen, Jette L. ;
Gasperini, Claudio ;
Palace, Jacqueline ;
Reich, Daniel S. ;
Banwell, Brenda ;
Montalban, Xavier ;
Barkhof, Frederik .
LANCET NEUROLOGY, 2016, 15 (03) :292-303
[8]   Correlation between contrast enhanced plaques and plaque diffusion restriction and their signal intensities in FLAIR images in patients who admitted with acute symptoms of multiple sclerosis [J].
Foroughi, Amin Abolhasani ;
Zare, Niloofar ;
Saeedi-Moghadam, Mahdi ;
Zeinali-Rafsanjani, Banafsheh ;
Nazeri, Masoume .
JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2021, 52 (01) :121-126
[9]  
Foroughi AA, 2017, NEURORADIOL J, V30, DOI 10.1177/1971400916678224
[10]   Comparison of SimoaTM and EllaTM to assess serum neurofilament-light chain in multiple sclerosis [J].
Gauthier, Audrey ;
Viel, Sebastien ;
Perret, Magali ;
Brocard, Guillaume ;
Casey, Romain ;
Lombard, Christine ;
Laurent-Chabalier, Sabine ;
Debouverie, Marc ;
Edan, Gilles ;
Vukusic, Sandra ;
Lebrun-Frenay, Christine ;
De Seze, Jerome ;
Laplaud, David Axel ;
Castelnovo, Giovanni ;
Gout, Olivier ;
Ruet, Aurelie ;
Moreau, Thibault ;
Casez, Olivier ;
Clavelou, Pierre ;
Berger, Eric ;
Zephir, Helene ;
Trouillet-Assant, Sophie ;
Thouvenot, Eric .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (05) :1141-1150